Spectrum Pharmaceuticals Announces 19 ZEVALIN Presentations at the 53rd Annual ... MarketWatch (press release) ... Phase I Trial of Zevalin Radioimmunotherapy with High-Dose Dispenzieri Hall GH Melphalan (HDM) and Autologous Stem Cell Transplant (ASCT) for Multiple Myeloma (MM) 6:00 PM-8:00 PM 3107 Poster Radioimmunotherapy (RIT) with 90yttrium Zevalin Followed ... |
